BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21908482)

  • 1. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica.
    Asgari N; Nielsen C; Stenager E; Kyvik KO; Lillevang ST
    Mult Scler; 2012 Jan; 18(1):23-30. PubMed ID: 21908482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
    Brum DG; Barreira AA; dos Santos AC; Kaimen-Maciel DR; Matiello M; Costa RM; Deghaide NH; Costa LS; Louzada-Junior P; Diniz PR; Comini-Frota ER; Mendes-Junior CT; Donadi EA
    Mult Scler; 2010 Jan; 16(1):21-9. PubMed ID: 19995845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort.
    Soelberg K; Nilsson AC; Nielsen C; Jarius S; Reindl M; Wildemann B; Lillevang ST; Asgari N
    Mult Scler Relat Disord; 2018 Apr; 21():97-102. PubMed ID: 29544193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
    Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
    J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.
    Deschamps R; Paturel L; Jeannin S; Chausson N; Olindo S; Béra O; Bellance R; Smadja D; Césaire D; Cabre P
    Mult Scler; 2011 Jan; 17(1):24-31. PubMed ID: 20861181
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    ; ; . PubMed ID: 19086079
    [No Abstract]   [Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.